Dublin, Aug. 04, 2023 (GLOBE NEWSWIRE) -- The "Wearable Injectors Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.
The global wearable injectors market is set to grow from $6.24 billion in 2021 to $7.16 billion in 2022, with a compound annual growth rate (CAGR) of 14.8%. The market is projected to reach $11.29 billion by 2026, exhibiting a CAGR of 12.0% during the forecast period.
The report highlights the impact of the Russia-Ukraine war on the global economic recovery from the COVID-19 pandemic. Economic sanctions, commodity price surges, and supply chain disruptions caused inflation across various markets worldwide. However, the wearable injectors market remains resilient, driven by the increasing prevalence of chronic diseases and the growing demand for drug delivery devices.
Key Highlights from the Report:
- Wearable injectors are drug delivery devices that adhere to the body, administering drugs subcutaneously over a preset time period.
- North America emerged as the largest region in the wearable injectors market in 2022, followed by Western Europe. The report covers regions including Asia-Pacific, Eastern Europe, South America, Middle East, and Africa.
- The main types of wearable injectors are on-body injectors and off-body injectors, catering to applications such as immuno-oncology, diabetes, and cardiovascular diseases.
- The rise in the number of diabetic and chronic disease patients, especially cardiovascular diseases and cancers, has contributed to the growth of the wearable injectors market.
- The high cost associated with wearable injectors might limit market growth. According to Drug Development and Delivery, wearable injectors are single-use systems with a cost ranging from $20 to $35 per unit.
- Companies in the wearable injectors manufacturing market are focusing on mergers and acquisitions to gain production capabilities and access to new markets.
Reasons to Purchase the Report:
- Gain a comprehensive global perspective with data covering 50+ geographies.
- Understand the impact of the COVID-19 pandemic on the market and its response as the situation improves.
- Assess the influence of the Russia-Ukraine war on agriculture, energy, mineral commodity supply, and its implications on the wearable injectors market.
- Measure the market's response to high global inflation.
- Create regional and country strategies based on local data and analysis.
- Identify investment opportunities in growth segments.
- Outperform competitors using forecast data and market trends.
- Understand customer preferences based on the latest market shares.
- Benchmark performance against key competitors.
- Utilize reliable high-quality data and analysis for internal and external presentations.
Companies Covered: The report includes insights on key players in the wearable injectors market, such as:
- Amgen
- Becton, Dickinson and Co.
- Enable Injections
- Insulet Corporation
- Ypsomed
- Medtronic
- Tandem Diabetes Care
- Valeritas
- West Pharmaceutical Services
- Sensile Medical AG
- Gerresheimer
- Dexcom
- Consort Medical
- United Therapeutics
- Buhler Motor GmbH
- Debiotech
- UNILIFE CORPORATION
- Cellnovo
The "Wearable Injectors Global Market Report 2023" provides a comprehensive perspective of the wearable injectors industry, offering valuable insights for businesses to make informed decisions and thrive in this dynamic market.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 175 |
| Forecast Period | 2022 - 2026 |
| Estimated Market Value (USD) in 2022 | $7.16 billion |
| Forecasted Market Value (USD) by 2026 | $11.29 billion |
| Compound Annual Growth Rate | 12.1% |
| Regions Covered | Global |
For more information about this report visit https://www.researchandmarkets.com/r/affbto
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
